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Genetic and environmental factors are important in the
pathogenesis of clinical and experimental chronic intestinal
inflammation. We investigated the influence of normal lu-
minal bacteria and several groups of selected bacterial
strains on spontaneous gastrointestinal and systemic in-
flammation in HLA-B27 transgenic rats. Rats maintained
germfree for 3–9 mo were compared with littermates con-
ventionalized with specific pathogen-free bacteria. Subse-
quently, germfree transgenic rats were colonized with
groups of five to eight bacteria that were either facultative
or strictly anaerobic. Transgenic germfree rats had no gas-
troduodenitis, colitis, or arthritis, but developed epididymi-
tis and dermatitis to the same degree as conventionalized
rats. Colonic proinflammatory cytokine expression was in-
creased in transgenic conventionalized rats but was unde-
tectable in germfree and nontransgenic rats. Colitis progres-
sively increased over the first 4 wk of bacterial exposure,
then plateaued. Only transgenic rats colonized with defined





colitis and gastritis. Normal luminal bacteria predictably
and uniformly induce chronic colonic, gastric and systemic
inflammation in B27 transgenic F344 rats, but all bacterial

























Both genetic and environmental factors have been docu-





 ulcerative colitis, and Crohn’s disease
(1). Substantial data from clinical observations and animal
models incriminate normal luminal bacteria or bacterial prod-
ucts in the initiation and perpetuation of chronic enterocolitis
and associated systemic inflammation (2), although the critical
bacterial components or antigen(s) are not yet known. Crohn’s
colitis and ileocolitis respond to treatment with metronidazole
(3) and ciprofloxacin or clarithromycin can induce longlasting
remission in Crohn’s disease (4, 5). In addition, ciprofloxacin is
effective as adjuvant therapy for ulcerative colitis (6). Subsero-
sal injection of purified bacterial cell wall polymers, such as
peptidoglycan-polysaccharide (PG-PS), induces chronic re-
lapsing granulomatous enterocolitis with systemic inflamma-
tion in genetically susceptible rats (7, 8), while small bowel
bacterial overgrowth causes spontaneous hepatobiliary inflam-
mation and reactivates arthritis (9, 10). Antibiotics, especially
those active against anaerobic bacteria, prevent and treat
hepatobiliary disorders and arthritis in a bacterial overgrowth
model and prevent indomethacin-induced enterocolitis (9–11).
Finally, axenic Lewis rats raised in a sterile environment do
not develop chronic intestinal inflammation after subcutane-
ous indomethacin injection, in contrast to littermates conven-
tionalized with specific pathogen free (SPF) bacteria (12).
The lumen of the distal ileum and colon is a complex eco-
system composed of over 200 different bacterial species, domi-





 (13). Recent evidence suggests that all enteric bacteria may
not have equal abilities to induce and perpetuate inflammation
(2). Several resident enteric bacterial species have been associ-
ated with Crohn’s disease and ulcerative colitis, and certain
strains have a preferential ability to induce chronic inflamma-

















(15), and serum antibodies to the latter three bacteria (16) are
specifically increased in Crohn’s disease. Concentrations of




(enterococcus, group D streptococci), are increased in ulcer-









 plays an essential role
in the pathogenesis of carrageenan-induced colitis in guinea

















 can induce arthritis in
susceptible rat strains (2, 18, 19).
The MHC is a powerful determinant of genetically medi-
ated immunoregulation. The MHC class I molecules are sur-






















m), which present intracellularly generated
antigen to CD8 T lymphocytes (20). In humans, several MHC
alleles are associated with susceptibility to certain disease
states. One of the strongest associations between the MHC
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and human disease is between HLA-B27, a MHC class I-mole-
cule, and seronegative spondylarthropathies, especially anky-
losing spondylitis and reactive arthritis (21). A number of
observations associate intestinal inflammation and luminal
bacteria with this group of disorders. A high prevalence of
spondyloarthropathy is found in patients with IBD, certain en-
teropathogenic bacteria predictably trigger B27-associated re-
active arthritis, extensive structural, and antigenic mimicry has
been documented between enteric bacteria and the HLA-B27
molecule. Moreover, at least subclinical ileocolitis has been
found in two-thirds of patients with spondyloarthropathies ex-
amined by ileocolonoscopy (22). A direct role for HLA-B27 in
these disorders is strongly supported by the observation that
rats transgenic for HLA-B27 spontaneously develop gas-
troduodenitis, colitis, arthritis, and spondylitis (23). Diarrhea,
which develops between 5 and 20 wk of age, is consistently the
earliest clinical manifestation. Arthritis usually follows the on-
set of colitis by several weeks (23, 24). A bacterial influence on
intestinal and joint inflammation was demonstrated by the lack
of colitis and arthritis in B27 transgenic rats raised under germ-
free conditions (25).
Although the initial study demonstrated that germfree B27
rats developed colitis upon introduction into a conventional or
SPF environment (25), this phenomenon was not systemati-
cally investigated. The aims of the present study were to examine
systematically the effects of introducing SPF luminal bacteria
on the initiation and perpetuation of spontaneous gastrointes-
tinal and systemic inflammation in germfree HLA-B27 trans-
genic rats, to characterize the kinetics of colonic inflammation
after exposure to bacteria, to examine the cytokine profiles in
the inflamed colonic tissues, and to determine whether some
bacterial species have a dominant role in the pathogenesis of






Transgenic rats of the 33-3 line on an inbred F344 back-






 microglobulin gene (23), were cesarean-derived into a germfree
(sterile) environment as previously described (25). The colony was
maintained by mating hemizygous transgenic females with nontrans-
genic males. Transgenic rats were identified by dot blot hybridization




















38) littermates raised in a germfree environment were divided into
two groups at 6–8 wk of age. One group (GF) remained in the sterile
isolators until necropsy at 3, 4, 6, or 9 mo of age. The second group
(CV) was conventionalized with SPF rat bacterial flora. Convention-
alization was accomplished by housing the GF rats with SPF Fischer
F344 rats purchased from Charles River Inc. (Raleigh, NC) for 4–12
h, swabbing the mouths of GF rats with a homogenate of feces of SPF
rats and placing bedding and feces from SPF rats into the CV rat
cage. These rats were then maintained in a room dedicated to SPF
rats. Subsequently, 26 additional 2-mo-old germfree transgenic rats
were colonized with defined bacterial species as detailed below and
maintained under gnotobiotic conditions for 1 mo before necropsy.
All rats were monitored weekly for clinical evidence of diarrhea and
arthritis, as detected by soiling of the perianal fur and ankle joint
erythema and swelling, respectively. CV rats were serially weighed,
and had ankle joint diameters measured with calipers (10) at least
weekly.
Before necropsy all rats underwent final blinded clinical examina-
tion of body weight, joint diameters, degree of hair loss, and diarrhea,




 asphyxiation within 3 h of removal from gno-
tobiotic isolators. Anticoagulated cardiac blood was taken for evalua-
tion of white blood cell count, hemoglobin, and hematocrit. The
cecum and colon were inspected grossly in a blinded fashion for evi-





, using a previously validated system (7, 8). The cecum, right co-
lon, rectum, ileum, jejunum, duodenum, and stomach were fixed in
10% buffered formalin. Spleen and liver were weighed. Right colonic
segments were snap frozen in iso-penthane for myeloperoxidase




GF rats were caged in Trexler flexible film
isolators using standard techniques (27). The germfree state was
monitored every 2 wk and at necropsy by fecal Gram stain and aero-
bic and anaerobic cultures of bedding and cecal contents.
 
Colonization with specific bacterial cocktails. 
 
At 2 mo of age,
germfree transgenic rats were transferred into separate isolators and
colonized with one of three different specific bacterial cocktails:











































as described above. A gnotobiotic rat colonized solely with CRAS
flora (28) was obtained from Charles River Inc. Bacteria in the
DESEP cocktail were isolated from Crohn’s disease patients by Prof.










) and by the Clinical Microbiology Laboratory of the University of













 was provided by Dr. Steven Simpson, Glaxo-Wellcome, Re-




 is a gift from Dr. A. B. On-
derdonk, Harvard University, Cambridge, MA, and originated from a
guinea pig with carageenan-induced colitis (17). Colonization with
DESEP and DESEP-B bacteria was accomplished by instilling 1 ml
of overnight cultures in brain–heart infusion, diluted in PBS, into the
 



















Bacteroides distasonis Streptococcus avium Streptococcus avium
 
CRBL #356 fusiform-shaped bacterium
 
Eubacterium contortum Eubacterium contortum
 
CRBL #492 fusiform-shaped bacterium
 
Peptostreptococcus productus Peptostreptococcus productus
 




CRBL #502 fusiform-shaped bacterium
CRBL #457 fusiform-shaped bacterium
*CRAS, Charles River Altered Schaedler.
 




stomach and rectum of germfree transgenic rats. Germfree B27 trans-
genic rats were colonized with CRAS bacteria by introducing a
CRAS flora rat into the germfree isolator and by swabbing their
mouths and rectums with fecal homogenates from this rat. Each
group of colonized rats was maintained under gnotobiotic conditions.
Successful bacterial colonization was confirmed by culturing and





Tissues were fixed in 10% neutral buffered formalin





m thickness, and stained with hematoxylin and eosin.
Coded samples were evaluated by a single observer (H.C. Rath) us-
ing light microscopy. Randomly selected sections were independently
scored by a second blinded investigator (R.B. Sartor) with excellent
correlation of scores. Cecal inflammation was quantitated by a histo-
logical score developed especially for this animal model (Table II).





 using similar criteria. Histologic scores were correlated








Methods of tissue preparation and the assay of




RIA was performed on supernatants of ho-


















 protein concentrations in the cecal
tissue we performed ELISAs, using standard techniques developed
by Dr. S. Poole (NI of Biological Standards and Controls, Hertford-









 serum S4B3 and incubated
overnight at 4°C. Samples diluted 1:20 were added and incubated
overnight at 4°C. The 1:1,000 diluted biotinylated immunoaffinity-




 polyclonal antibody was added and in-
cubated for 1 h. Avidin-horseradish peroxidase (Dako Corp., Carpin-








-tetramethylbenzidine liquid substrate system
(Sigma, St. Louis, MO) were used as the conjugation enzyme and
substrate.
 
Polymerase chain reaction analysis. 
 






















 Taq buffer II (Perkin Elmer Cetus Corp., Nor-













































































C for 1.5 min. Negative controls without cDNA were amplified
with each PCR experiment. To confirm the log-linearity of the ampli-
fication process, aliquots of the samples were taken at different cycles
and analyzed by electrophoresis on a 2% agarose gel containing
ethidium bromide. Primers specific for rat cytokines were constructed
according to published sequences (30-37, Feeser, W., and B.D. Fre-

















































































































, 59- TGG TGT GTT GGT GAG
GCT CAC -39), b - Actin (59- ACC ACA GCT GAG AGG GAA
ATC G-39, 59- AGA GGT CTT TAC GGA TGT CAA CG-39). Au-
thenticity of the PCR products was confirmed using specific restric-
tion enzymes.
Statistical methods. All data are expressed as mean6SEM. To
test for differences between the groups, the ANOVA was used. Sam-
ples with equal distribution were compared using the t test. To com-
pare nominal variables between groups the x2-test was performed. P ,
0.05 was considered statistically significant.
Results
Inflammation in germfree vs conventionalized transgenic rats
The data shown are from 6-mo-old rats, but are representative
of all other rats euthanized over the study period of 3–9 mo.
Clinical features. Transgenic CV rats (n 5 21) were the
only group to show diarrhea or clinical signs of arthritis (83%
incidence of both diarrhea and arthritis in the transgenic CV
group vs 0% in the transgenic germfree [n 5 12] and nontrans-
genic CV [n 5 10] littermates [P , 0.005]). The onset of the
nonbloody diarrhea and arthritis was variable in the CV trans-
genic rats, but achieved an incidence of 83% by 3 mo of age.
Arthritis followed an undulating pattern with spontaneous re-
mission, and was relatively mild.
There were no differences in weight gain, joint diameters,
or the incidence of hair loss, dermatitis, orchitis, and epididymitis
in transgenic conventionalized rats compared with transgenic
germfree littermates (hair loss occurred in 100% of transgenic
Table II. Histological Score to Quantify the Degree of 
Gastrointestinal Inflammation in B27 Transgenic Rats
Criterion
Score Add
0 1 2 3 4 10.5–11 for each
Inflammatory cells – ↑ ↑↑ ↑↑↑ ↑↑↑ ulcer
Goblet cells – ↓ ↓↓ ↓↓↓ ↓↓↓ crypt abscess
Mucosa thickening – ↑ ↑↑ ↑↑↑ ↑↑↑
Submucosa cell infiltration – – ↑ ↑↑ ↑↑↑
Destruction of architecture – – – ↑ ↑↑
↑ , increased; ↓ , decreased.
Figure 1. Lack of colonic inflammation in germfree B27 transgenic 
rats in contrast to SPF rats. Gross (h) and histological ( ) signs of in-
flammation were graded in a blinded fashion using a score from 0–4 as 
outlined in the Methods section. Tissue myeloperoxidase activity (j) 
was normalized against the colonic tissue weight. *P , 0.001, ‡P , 
0.0001, §P , 0.005 vs transgenic GF. NT, nontransgenic; TG, HLA-
B27/b2m transgenic; CV, conventionalized with specific pathogen 
free enteric bacteria; GF, germfree (sterile).
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rats in each group by 6 mo of age and testicular inflammation
was present in 100% of males).
Colonic inflammation. At necropsy the intestine was grossly
evaluated for inflammatory lesions in a blinded fashion. Trans-
genic CV rats had significantly more thickening of the cecal
and colonic walls than transgenic GF and nontransgenic CV
littermates (P , 0.001; Fig. 1); the latter two groups had no de-
tectable lesions. Adenomatous polyps and adenocarcinomas
were not seen.
Similar to the gross observations, transgenic CV rats had
significantly more histologic cecal inflammation (P , 0.0001)
than GF and CV nontransgenic littermates (Fig. 1). Histologic
inflammatory scores were not significantly different between
GF transgenic and nontransgenic CV rats. Cecal inflammation
in CV transgenic rats was characterized by predominantly
mononuclear cell infiltration of the lamina propria with scat-
tered eosinophils and very few neutrophils (Fig. 2, A and B).
Scattered foci of these inflammatory cells only rarely extended
to the submucosa in the most severely inflamed regions. In ad-
dition, transgenic CV rats had marked thickening of the mu-
cosa, crypt hyperplasia with rare crypt abscesses, reduction of
mucus-secreting goblet cells, and early ulcerations limited to
the mucosa, but no granulomas or neoplasms. In contrast, co-
lonic sections from GF transgenic rats showed almost no evi-
dence of inflammation, with thin cecal walls, abundant goblet
cells, no cellular infiltration and no crypt abnormalities (Fig. 2
C). These lesions were similar to those previously described in
conventionally housed B27 transgenic rats (23–25).
To quantitate the degree of neutrophilic or eosinophilic cell
infiltration in the intestine, tissue MPO activity was measured
in the proximal transverse colon. Colonic MPO activity was in-
creased in transgenic CV rats (P , 0.005) compared with trans-
genic GF and nontransgenic rats; no differences were seen be-
tween the transgenic GF and nontransgenic groups (Fig. 1).
Tissue IL-1a protein concentrations in the transverse colon
were increased in transgenic CV rats (9,57561,502 pg/gram tis-
sue) compared with undetectable levels in transgenic GF and
nontransgenic CV rats (,20 pg/gram; P , 0.0001). Elevated
mRNA levels of the monokines IL-1a, IL-1b, and TNF-a were
demonstrated in the inflamed colonic tissues of the transgenic
CV rats but were undetectable in transgenic GF rats (Fig. 3).
In addition, we observed an increase in IL-6 mRNA expres-
sion in some of the transgenic CV animals (data not shown).
Figure 2. Histological features of cecal inflammation in B27 transgenic CV or GF rats. (A) The cecum of transgenic rats conventionalized with 
SPF bacteria exhibits thickening of the mucosa and inflammatory cell infiltration with predominantly mononuclear cells and scattered eosino-
phils but only occasional neutrophils (3100). (B) Higher magnification (3400) shows increased numbers of mononuclear cells in the lamina pro-
pria and a crypt abscess. (C) In contrast, germfree transgenic rats show normal cecal histology with normal crypts, abundant goblet cells, a small 
number of lamina propria mononuclear cells, no thickening of the mucosa, and no ulcerations or crypt abscesses (3100).
Figure 3. Expression of IL-1a, IL-1b, IL-1RA,TNF-a, and IFN-g 
mRNA in colonic tissues of transgenic GF and CV rats and nontrans-
genic CV control animals. Total RNA was reverse transcribed and 
amplified for various cycles by the polymerase chain reaction (23–40 
cycles depending on the cytokine and according to the methods de-
scribed above). b-actin was used to verify equal loading of cDNA.
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All colons had detectable IL-1RA expression, which was in-
creased after bacterial exposure. Low levels of IL-1a and
IL-1b mRNA expression were occasionally seen in nontrans-
genic CV rats. IFN-g mRNA was strongly elevated in rats with
intestinal inflammation compared with the noninflamed tis-
sues of transgenic GF and nontransgenic CV rats (Fig. 3).
Gastric and small intestinal inflammation. The stomach of
transgenic CV rats was inflamed predominantly in the antrum
(Fig. 4, A and B) and less extensively in the proximal glandular
portion. As in the cecum, the blinded histologic scores of in-
flammation (Fig. 5) in these areas of the stomach were signifi-
cantly increased in transgenic CV rats (P , 0.0001) compared
with GF littermates. GF transgenic and CV nontransgenic rats
had similar histologic scores. No inflammation was detectable
in the squamous portion of the stomach in any group.
Duodenal inflammation (Fig. 5) in GF transgenic rats was
less than in CV littermates (P , 0.005) and was not different
from CV nontransgenic rats. No consistent inflammatory
changes were seen in the jejunum and ileum of CV transgenic
rats and, when present, were less extensive than in the duode-
num and colon. There were no significant differences in ileitis
in GF and CV transgenic rats (data not shown).
Systemic inflammation. Hemoglobin concentrations, he-
matocrits, spleen, and liver weights (data not shown) showed
no significant difference between CV and GF transgenic ani-
mals. Transgenic CV rats had the highest degree of leukocyto-
sis (16.260.9; P , 0.001), but GF transgenic rats also had ele-
vated white blood cell concentrations (11.160.4) relative to
nontransgenic controls (5.360.3; P , 0.05).
Time course of inflammation after bacterial exposure
No significant differences in gross, histologic, or biochemical
parameters of chronic intestinal inflammation were noted
among transgenic CV rats examined between 3 mo and 9 mo
of age (after 1.5–7 mo of bacterial exposure). To determine the
kinetics of the onset of inflammation after bacterial coloniza-
tion, transgenic rats were observed for 1–4 wk after exposure
to SPF bacteria (n 5 5/group; Fig. 6). Colonic MPO levels pro-
gressively increased and were significantly elevated at 4 wk (P ,
0.05). Gross and histologic assessment of colonic inflammation
followed the same time course (data not shown). Arthritis was
not seen during this brief period of bacterial exposure.
Colonization of transgenic rats with defined bacterial cocktails
To determine whether normal flora bacteria differ in their
ability to induce inflammation, B27 transgenic rats were colo-
nized with groups of defined bacteria. Neither diarrhea nor ar-
thritis was observed in the gnotobiotic groups and GF or CV
controls over the 1 mo of bacterial exposure. Cecal inflamma-
tion occurred in CRAS- and DESEP-B–colonized transgenic
animals, but not in DESEP and GF rats, as shown by gross and
histologic observations as well as tissue MPO and IL-1b pro-
tein concentration (Fig. 7 and Table III). Colitis was consis-
tently highest in the DESEP-B group of gnotobiotic rats by all
Figure 4. Histology of gastric inflammation in B27 transgenic CV and GF rats. (A) The mucosa in the antrum in transgenic rats exposed to bac-
teria was thickened and infiltrated with predominantly mononuclear cells and scattered eosinophils (3100). (B) In contrast no inflammation was 
seen in germfree transgenic rats (3100).
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observed parameters. Gastritis was evident histologically in all
gnotobiotic groups but was significantly higher than GF rats
only in DESEP-B animals (Fig. 7); however, gastritis and cecal
inflammation in the DESEP-B group did not reach the degree
of inflammation observed in transgenic CV rats. The white
blood cell count was not elevated over GF values in any gnoto-
biotic group, in contrast to transgenic CV rats.
Discussion
It was previously reported that B27 transgenic rats raised in an
environment free of bacteria do not develop colitis or arthritis
(25). However, even in the germfree state, these rats develop
orchitis, alopecia, and dermatitis with incidence and severity
similar to that of conventionalized B27 transgenic rats. The
present study, which was conducted in a different gnotobiotic
facility, confirms the previous observations and extends these
results by: (a) demonstrating that transgenic rats conventional-
ized with SPF enteric bacteria develop arthritis; (b) document-
ing the kinetics of the inflammatory response after bacterial
colonization; (c) elucidating a selective cytokine profile of the
inflamed colon; (d) demonstrating a requirement for bacteria
in the pathogenesis of gastroduodenal inflammation; and (e)
showing that some resident enteric bacteria are more active
than others in inducing inflammation in this model.
These observations strongly incriminate normal flora bac-
teria in the pathogenesis of chronic intestinal inflammation in
genetically susceptible hosts, since pathogenic bacteria, vi-
ruses, and parasites were absent in transgenic rats that devel-
oped colitis, gastroduodenitis, and arthritis and defined, sim-
plified microflora induced similar lesions. These results agree
with previous observations that germfree Lewis rats treated
with subcutaneous indomethacin have attenuated, self-limited
small intestinal inflammation and no evidence of cecal or sys-
temic inflammation (12). A similar requirement for normal
flora bacteria has been observed in IL-2 and IL-10–deficient
mice, which have attenuated inflammation in SPF environ-
ments (38, 39), compared with conventional conditions. More-
over, IL-2–deficient mice have no clinical or histologic colitis
in the germfree state (38). These results are entirely consistent
with observations that antibiotics, especially those which are
effective against anaerobes, prevent experimental enterocolitis
in several animal models and are therapeutic for Crohn’s coli-
tis and indomethacin-induced enteropathy (3, 9, 11, 40–42).
Our results indicate that not all enteric bacteria have equal
abilities to induce gastrointestinal inflammation. HLA-B27
transgenic rats colonized with a combination of E. contortum,
P. productus, E. coli, S. faecum, and S. avium isolated from
Crohn’s disease patients (DESEP) unexpectedly had no signif-
icant increase in colitis or gastritis over that seen in GF rats,
despite the fact that these specific strains were chosen because
of their postulated role in IBD (2) and because they represent
Figure 5. Gastritis (  glandular portion and  antrum) and duoden-
itis (j) in B27 transgenic CV and GF rats. Histological signs of in-
flammation was graded in a blinded fashion using a score from 0–4 as 
outlined in the Methods section. *P , 0.0001 and ‡P , 0.005 vs trans-
genic GF.
Figure 6. Time course of colitis in B27 transgenic rats conventional-
ized with SPF bacteria. The degree of colitis was measured by colonic 
myeloperoxidase (MPO) concentrations. *P , 0.01 vs nontransgenic 
CV, transgenic GF, and transgenic CV after 1 wk of exposure.
Table III. Colitis, as Determined by the Gross Gut Score, Myeloperoxidase, and IL-1b Protein Concentration in Cecal Tissue from 
Transgenic Rats Colonized with Different Bacterial Floras
GF CRAS DESEP DESEP-B CV
Gross Gut Score 060 060 060 0.3960.1* 1.1960.1
Myeloperoxidase
U/gram tissue
0.1860.02 0.5060.04§ 0.3060.04 0.5560.09‡ 1.2460.14
IL-1b protein
 pg/gram tissue
494683 26156757¶ 12376288 1062661578i 968661603
*P , 0.001 vs GF,  CRAS,  and DESEP; ‡P , 0.01 vs DESEP, P , 0.0005 vs GF, and P , 0.005 vs CV; §P , 0.0001 vs GF; iP , 0.0001 vs DESEP and
GF, P , 0.001 vs CRAS; ¶P , 0.05 vs GF. Mean±SEM. See Table I for description of DESEP and DESEP-B.
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some of the most common aerobic and anaerobic constituents
of the normal enteric flora (13). PG-PS from the first four of
these bacterial strains induces arthritis after peritoneal injec-
tion (18,19), and intramurally-injected PG-PS from S. faecum
causes chronic granulomatous enterocolitis (8). It is possible
that increased serum antibodies to Eubacteria and Peptostrep-
tococci in Crohn’s disease patients (16) merely reflect en-
hanced mucosal absorption and/or heightened host immunore-
sponsiveness to these bacterial species, which are selectively
increased in this disorder (15).
Significantly increased colitis and gastritis in transgenic rats
additionally colonized with B. vulgatus (DESEP-B) strongly
implicate this organism in the pathogenesis of chronic intesti-
nal inflammation. Another Bacteroides strain (B. distasonis) is
a component of the CRAS flora, which induced an intermedi-
ate degree of colitis in our study. These observations are con-
sistent with increased luminal concentrations of Bacteroides
spp. in Crohn’s disease patients, and the ability of metronida-
zole to treat Crohn’s colitis (3), and, colitis and gastritis in B27
transgenic rats conventionalized with SPF bacteria (40). Of
therapeutic importance, metronidazole administration for up
to 6 mo chronically suppresses luminal concentrations of
Bacteroides spp., and the therapeutic efficacy of this antibiotic
in Crohn’s disease closely correlates with fecal Bacteroides
concentrations (14). Similarly, Lichtman et al. (9) showed that
chronic metronidazole therapy eliminated Bacteroides spp.
and prevented hepatobiliary inflammation in rats with jejunal
self-filling blind loops. In a series of experiments, Onderdonk
et al. (17) demonstrated that B. vulgatus was the dominant
bacterial stimulus in carrageenan-induced colitis in guinea
pigs. Furthermore, Bacteroides fragilis enterotoxin increases
mucosal permeability and epithelial internalization of enteric
bacteria (43). Together, these results demonstrate a consistent
role for Bacteroides spp., especially B. vulgatus, in the patho-
genesis of chronic intestinal inflammation. However, inflam-
mation in the DESEP-B groups was less than littermates con-
ventionalized with SPF bacteria, suggesting that additional
bacterial interactions are involved in the complex microenvi-
ronment of the conventional host. It is conceivable that some
bacterial strains protect against gastrointestinal inflammation
while others have a predominantly aggressive role, probably
with synergistic activities. Furthermore, the difference be-
tween gastrointestinal inflammation in rats colonized with
CRAS flora and SPF conventionalized rats indicate that, even
though the CRAS flora were used to initially populate the ma-
jority of commercially available rodents in the United States
(28), SPF rats have evolved a functionally distinct flora.
In view of the requirement for luminal bacteria in the gene-
sis of intestinal inflammation, the consistent presence of gas-
troduodenitis and the relatively infrequent and mild distal ile-
itis is somewhat surprising. The stomach and proximal small
intestine are mainly colonized by aerobic bacteria, whereas
high concentrations of predominantly anaerobic bacteria are
in intimate contact with the mucosa of the distal ileum, cecum,
and colon (13). But the proximal gastrointestinal tract of rats is
exposed to high concentrations of swallowed aerobic and
anaerobic bacteria from oropharyngeal secretions, food, and
ingested feces. Although gastric acid kills most of these in-
gested bacteria, nonviable bacterial components such as PG-PS
polymers are capable of inducing and perpetuating intestinal
and systemic inflammation (2, 10, 44). Furthermore, a focus of
inflammation in the stomach and duodenum with relative
sparing of the ileum is a consistent feature of the inflammatory
response in IL-10, IL-2, TGF-b, and G protein–deficient mice
(38, 39, 45, 46), and histologic evidence of antral gastritis oc-
curs in up to 60% of Crohn’s disease patients (47). Although
we did not observe consistent gross or histologic evidence of il-
eal inflammation in the B27 transgenic rats, Aiko and Grisham
(48) showed increased ileal MPO concentrations and dry
weights but no increased ileal mucosal permeability in these rats.
The profile of cytokines and biochemical markers in B27
transgenic rats exposed to enteric bacteria suggests that mecha-
nisms of tissue injury are similar to those described in human
IBD (1, 49). Increased expression of the monokines IL-1a, IL-1b,
IL-1RA, TNF-a, and IL-6 in the inflamed colons of transgenic
rats exposed to bacteria incriminate activated macrophages,
whereas IFN-g is a product of activated T lymphocytes and
natural killer cells. Histologic analysis of the inflamed colonic
tissues demonstrates infiltrations of macrophages and lympho-
cytes. Elevated tissue MPO concentrations could be a conse-
quence of infiltration by either neutrophils or eosinophils (29),
although the latter cell type was seen far more frequently on
histologic assessment than the former. Similar profiles of cy-
tokines have been described in human IBD (1, 49) and numer-
ous animal models of experimental intestinal inflammation (50).
As previously observed (25), dermatitis and epididymitis
were not dependent on bacterial colonization. In addition, pe-
ripheral blood white blood cell levels were slightly but signifi-
cantly higher in GF transgenic rats than in noninflammatory
nontransgenic controls, probably as a consequence of ongoing
dermatitis and epididymoorchitis. It remains to be determined
whether these systemic inflammatory lesions are totally inde-
pendent of bacterial stimulation, or whether they arise from
exposure to small concentrations of bacterial cell wall compo-
nents and antigens ingested in autoclaved rat chow, bedding,
and water.
The relationship between luminal bacteria or bacterial
products, colitis, and joint inflammation is well established (2,
7, 8, 10, 19, 21, 22, 51–53). Oligoarticular peripheral arthritis is
associated with ulcerative colitis, Crohn’s disease (especially of
Figure 7. Histologic inflammatory scores of the cecum ( ) and an-
trum (j) revealed significant differences between DESEP-B vs 
DESEP or GF rats. CRAS colonized animals had higher histologic 
inflammatory scores in the cecum, but not in the antrum, than GF 
rats. *P , 0.001 vs DESEP, GF, and CV; ‡P , 0.05 vs DESEP and P , 
0.0001 vs GF and CV; §P , 0.05 vs GF and P , 0.0001 vs CV. See Ta-
ble I for descriptions of CRAS, DESEP, and DESEP-B.
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the colon), and a number of enteric infections. The appearance
of arthritis after diarrhea in B27 transgenic CV rats agrees with
previous observations (23–25) and further supports a central
role for intestinal inflammation in the spondyloarthropathies.
One hypothesis that accounts for this role is that enteric bacte-
ria and bacterial products such as LPS, PG-PS, FMLP, and
membrane antigens are absorbed to a greater degree during
intestinal inflammation, leading to systemic distribution of
these phlogistic bacterial components and subsequent extrain-
testinal inflammation, such as arthritis (2, 10, 22). This hypoth-
esis is supported by increased mucosal uptake of luminal PG-PS
after experimental colonic or jejunal injury in the acetic acid
and jejunal bacterial overgrowth models, respectively (54, 55),
reactivation of arthritis by systemically injected PG-PS or LPS
(51, 52), and the presence of bacterial antigens within synovial
leukocytes in patients with B27-associated reactive arthritis
(56, 57).
In summary, this study indicates that normal luminal bacte-
ria play an important role in the pathogenesis of spontaneous
colitis, gastroduodenitis, and peripheral arthritis in genetically
susceptible B27 transgenic rats, but that not all resident bacte-
rial species have equal abilities to induce inflammation. Identi-
fication of the subpopulations of luminal bacteria that exert a
dominant role in induction of colitis has important therapeutic
implications for IBD patients. Further studies of B27 trans-
genic rats should help determine whether Bacteroides spp.
have a unique, essential role and whether there are other bac-
terial strains that have independent, synergistic or even protec-
tive activities.
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